Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Lim Y, Gondek L, Li L, Wang Q, Ma H, Ma H, et al. Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia. Sci Transl Med. 2015;7(291):291ra96.

Pizzi M, Gaudiano M, Todaro M, Inghirami G. Anaplastic lymphoma kinase: activating mechanisms and signaling pathways. Front Biosci (Schol Ed). 2015;7:283-305.

Boi M, Zucca E, Inghirami G, Bertoni F. Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas. Br J Haematol. 2015;168(6):771-83.

Moscat J, Richardson A, Diaz-Meco MT. Nutrient stress revamps cancer cell metabolism. Cell Res. 2015;25(5):537-8.

Sullivan HC, Fisher KE, Hoffa AL, Wang J, Saxe D, Siddiqui MT, et al. The role of immunohistochemical analysis in the evaluation of EML4-ALK gene rearrangement in lung cancer. Appl Immunohistochem Mol Morphol. 2015;23(4):239-44.

Gerke TA, Martin NE, Ding Z, Nuttall EJ, Stack EC, Giovannucci E, et al. Evaluating a 4-marker signature of aggressive prostate cancer using time-dependent AUC. Prostate. 2015;75(16):1926-33.

Li Q, Li Y, Gu B, Fang L, Zhou P, Bao S, et al. Akt Phosphorylates Wnt Coactivator and Chromatin Effector Pygo2 at Serine 48 to Antagonize Its Ubiquitin/Proteasome-mediated Degradation. J Biol Chem. 2015;290(35):21553-67.

Greenblatt MB, Nowak JA, Quade CC, Tanasijevic M, Lindeman N, Jarolim P. Impact of a prospective review program for reference laboratory testing requests. Am J Clin Pathol. 2015;143(5):627-34.

Gardner TJ, Cohen T, Redmann V, Lau Z, Felsenfeld D, Tortorella D. Development of a high-content screen for the identification of inhibitors directed against the early steps of the cytomegalovirus infectious cycle. Antiviral Res. 2015;113:49-61.

Robinson D, Van Allen EM, Wu Y-, Schultz N, Lonigro RJ, Mosquera J-, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015;161(5):1215-1228.